Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ionis Pharmaceuticals

32.95
+1.243.91%
Volume:1.04M
Turnover:34.05M
Market Cap:5.24B
PE:-10.99
High:33.20
Open:32.25
Low:32.01
Close:31.71
Loading ...

Ionis Pharmaceuticals Shares up 1.6% After Q4 Sales Beat

THOMSON REUTERS
·
19 Feb

Ionis Pharmaceuticals trading halted, volatility trading pause

TIPRANKS
·
19 Feb

Stock Track | Ionis Pharmaceuticals Surges 6.42% Pre-Market on Strong Q4 Beat and Bright 2025 Outlook

Stock Track
·
19 Feb

Ionis Pharmaceuticals Shares up 5% Premarket After Q4 Sales Beat

THOMSON REUTERS
·
19 Feb

Ionis Pharmaceuticals (IONS) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
19 Feb

Ionis Pharmaceuticals Q4 Net Loss Widens, Revenue Falls; 2025 Sales Guidance Set

MT Newswires Live
·
19 Feb

BUZZ-Ionis Pharma rises on better-than-expected quarterly results

Reuters
·
19 Feb

Ionis Pharmaceuticals sees FY25 revenue $600M, consensus $677.05M

TIPRANKS
·
19 Feb

Ionis Pharmaceuticals: Q4 Earnings Snapshot

Associated Press Finance
·
19 Feb

Ionis Pharmaceuticals Forecasts 2025 Revenue Of Over $600M Versus Consensus Of $675.95M

Benzinga
·
19 Feb

Ionis Pharmaceuticals Inc: Sees 2025 Revenue Above $600 Mln

THOMSON REUTERS
·
19 Feb

Ionis Pharmaceuticals Inc Q4 Shr View $-1.12 -- Lseg Ibes Data

THOMSON REUTERS
·
19 Feb

Ionis Pharmaceuticals Inc FY2025 REV View $675.9 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
19 Feb

Ionis Pharmaceuticals Inc Qtrly Shr Loss $0.66

THOMSON REUTERS
·
19 Feb

Ionis Pharmaceuticals Q4 2024 GAAP EPS $(0.66) Beats $(1.10) Estimate, Sales $227.00M Beat $137.60M Estimate

Benzinga
·
19 Feb

BRIEF-Ionis Pharmaceuticals Q4 Revenue USD 227 Million Vs. IBES Estimate USD 137.6 Million

Reuters
·
19 Feb

Ionis Pharmaceuticals Q4 Operating Income USD -110 Million

THOMSON REUTERS
·
19 Feb

Ionis Pharmaceuticals Q4 Adjusted Operating Expenses USD 301 Million

THOMSON REUTERS
·
19 Feb

Ionis Pharmaceuticals Q4 Adjusted Operating Income USD -74 Million VS. Ibes Estimate USD -176.5 Million

THOMSON REUTERS
·
19 Feb

Ionis Pharmaceuticals Q4 Operating Expenses USD 337 Million

THOMSON REUTERS
·
19 Feb